Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Condition(s):Myocardial InfarctionLast Updated:February 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Myocardial InfarctionLast Updated:February 8, 2024Recruiting
Condition(s):Cardiogenic Shock; Myocardial InfarctionLast Updated:February 24, 2023Recruiting
Condition(s):Non ST Elevation Myocardial Infarction; Unstable AnginaLast Updated:July 20, 2016Completed
Condition(s):Myocardial InfarctionLast Updated:April 9, 2021Completed
Condition(s):Non-ST-elevation Myocardial InfarctionLast Updated:May 2, 2017Completed
Condition(s):Primary Prevention; Tachycardia, Ventricular; Sudden Cardiac DeathLast Updated:January 12, 2015Completed
Condition(s):Acute Coronary Syndrome; STEMI; NSTEMI – Non-ST Segment Elevation MI; PLATELET AGGREGATION; INDIVIDUALIZED THERAPYLast Updated:April 30, 2020Completed
Condition(s):Myocardial Infarction; Diastolic DysfunctionLast Updated:October 14, 2021Unknown status
Condition(s):Aortic Valve Stenosis; Transcatheter Aortic Valve Implantation; EmergenciesLast Updated:September 6, 2022Not yet recruiting
Condition(s):Acute Myocardial InfarctionLast Updated:June 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.